Scherle Peggy
- SEC CIK
- 0001824632
No open-market purchases or sales filed in the past year.
Current role at each company
- PRLD Prelude Therapeutics IncChief Scientific Officeras of Feb 5, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Scherle Peggy as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 30, 2021 (view filing) | Aug 26-27 | 4 days | Scherle PeggyChief Scientific Officer | SSale | −7.71K | $35.75 | −$275.8K | −4.3%172.9K after | 4 lots |
| Aug 17, 2021 (view filing) | Aug 13 | 4 days | Scherle PeggyChief Scientific Officer | SSale | −2.29K | $35.07 | −$80.2K | −1.3%172.9K after | |
| Jul 29, 2021 (view filing) | Jul 27 | 2 days | Scherle PeggyChief Scientific Officer | SSale | −20.0K | $35.47 | −$709.4K | −10.4%172.9K after | 2 lots |